141 related articles for article (PubMed ID: 12899522)
1. Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism.
Schuster I; Egger H; Reddy GS; Vorisek G
Recent Results Cancer Res; 2003; 164():169-88. PubMed ID: 12899522
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of vitamin D hydroxylases in human keratinocytes.
Schuster I; Egger H; Bikle D; Herzig G; Reddy GS; Stuetz A; Stuetz P; Vorisek G
Steroids; 2001; 66(3-5):409-22. PubMed ID: 11179750
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes.
Schuster I; Egger H; Astecker N; Herzig G; Schüssler M; Vorisek G
Steroids; 2001; 66(3-5):451-62. PubMed ID: 11179754
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of vitamin D hydroxylases: structure-activity relationships.
Schuster I; Egger H; Nussbaumer P; Kroemer RT
J Cell Biochem; 2003 Feb; 88(2):372-80. PubMed ID: 12520539
[TBL] [Abstract][Full Text] [Related]
5. Insights into Vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS).
Masuda S; Kaufmann M; Byford V; Gao M; St-Arnaud R; Arabian A; Makin HL; Knutson JC; Strugnell S; Jones G
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):149-53. PubMed ID: 15225763
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
Sakaki T; Sawada N; Abe D; Komai K; Shiozawa S; Nonaka Y; Nakagawa K; Okano T; Ohta M; Inouye K
Biochem Pharmacol; 2003 Jun; 65(12):1957-65. PubMed ID: 12787875
[TBL] [Abstract][Full Text] [Related]
7. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.
Sakaki T; Sawada N; Komai K; Shiozawa S; Yamada S; Yamamoto K; Ohyama Y; Inouye K
Eur J Biochem; 2000 Oct; 267(20):6158-65. PubMed ID: 11012668
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1alpha,25-dihydroxyvitamin D3.
Miyamoto Y; Shinki T; Yamamoto K; Ohyama Y; Iwasaki H; Hosotani R; Kasama T; Takayama H; Yamada S; Suda T
J Biol Chem; 1997 May; 272(22):14115-9. PubMed ID: 9162038
[TBL] [Abstract][Full Text] [Related]
9. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
Swami S; Krishnan AV; Peehl DM; Feldman D
Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D analogues targeting CYP24 in chronic kidney disease.
Posner GH; Helvig C; Cuerrier D; Collop D; Kharebov A; Ryder K; Epps T; Petkovich M
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):13-9. PubMed ID: 20347976
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
12. UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor.
Vantieghem K; Overbergh L; Carmeliet G; De Haes P; Bouillon R; Segaert S
J Cell Biochem; 2006 Sep; 99(1):229-40. PubMed ID: 16598763
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
Kusudo T; Sakaki T; Abe D; Fujishima T; Kittaka A; Takayama H; Ohta M; Inouye K
Biochem Biophys Res Commun; 2003 Oct; 309(4):885-92. PubMed ID: 13679056
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
[TBL] [Abstract][Full Text] [Related]
15. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer.
Parise RA; Egorin MJ; Kanterewicz B; Taimi M; Petkovich M; Lew AM; Chuang SS; Nichols M; El-Hefnawy T; Hershberger PA
Int J Cancer; 2006 Oct; 119(8):1819-28. PubMed ID: 16708384
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of vitamin D metabolism--new concepts and perspectives.
Schuster I; Egger H; Herzig G; Reddy GS; Schmid JA; Schüssler M; Vorisek G
Anticancer Res; 2006; 26(4A):2653-68. PubMed ID: 16886676
[TBL] [Abstract][Full Text] [Related]
17. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.
Farhan H; Wähälä K; Cross HS
J Steroid Biochem Mol Biol; 2003 Mar; 84(4):423-9. PubMed ID: 12732287
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vitamin D-mediated induction of the CYP 24 transcription.
Tashiro K; Abe T; Oue N; Yasui W; Ryoji M
Mol Cell Endocrinol; 2004 Oct; 226(1-2):27-32. PubMed ID: 15489002
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of vitamin D3 by cytochromes P450.
Sakaki T; Kagawa N; Yamamoto K; Inouye K
Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
